Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M306220200 on July 10, 2003

J. Biol. Chem., Vol. 278, Issue 38, 35950-35958, September 19, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/38/35950    most recent
M306220200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crist, S. A.
Right arrow Articles by Ratliff, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crist, S. A.
Right arrow Articles by Ratliff, T. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structure/Function Analysis of the Murine CD95L Promoter Reveals the Identification of a Novel Transcriptional Repressor and Functional CD28 Response Element*

Scott A. Crist, Thomas S. Griffith and Timothy L. Ratliff {ddagger}

From the Department of Urology and the Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa 52242

CD28 costimulation, an important second signal for antigen-mediated T cell activation, is known to enhance expression of several genes important for the regulation of CD4+ T cell effector function including interleukin-2 and CD154. Previous studies demonstrate CD28-mediated enhancement of the transcription and expression of Fas ligand (CD95L) in T cell lines, suggesting a regulatory link between CD28 and CD95L expression. These results served as the basis for structure/function analysis of the CD95L promoter to elucidate the mechanism for CD28-mediated enhancement of CD95L. In this report, we describe a novel response element, located at -210 to -201 bp upstream of the transcription start site, that confers CD28 responsiveness to the CD95L gene. This response element is homologous to the CD28 response element (CD28RE) previously identified in the IL-2 promoter and bears structural similarities to a newly identified CD28RE in the CD154 promoter. We further demonstrate that CD28-mediated enhancement of promoter activity correlates with enhanced expression of CD95L mRNA, cell surface expression of CD95L protein, and increased apoptosis of CD95+ target cells. These results demonstrate a direct transcriptional regulatory role for CD28 in CD95L-mediated functional activity in CD4+ T cells. Mutational analysis of the CD95L promoter also reveals a novel transcriptional repressor element located ~60 bp 5' of the CD28RE. The repressor element bears sequence homology to an activator protein-1 element, constitutively binds c-Fos but not c-Jun, and is activation-independent.


Received for publication, June 12, 2003 , and in revised form, July 9, 2003.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Urology, 3206 MERF, Iowa City, IA 52245. Tel.: 319-335-8107; Fax: 319-353-4556; E-mail: Tim-Ratliff{at}uiowa.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Villa-Morales, J. Santos, E. Perez-Gomez, M. Quintanilla, and J. Fernandez-Piqueras
A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas
Cancer Res., June 1, 2007; 67(11): 5107 - 5116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-L. Yao, Y.-C. Lin, P. Sawhney, and J. H. Richburg
Transcriptional Regulation of FasL Expression and Participation of sTNF-{alpha} in Response to Sertoli Cell Injury
J. Biol. Chem., February 23, 2007; 282(8): 5420 - 5431.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. P. Singh, M. Nagarkatti, and P. S. Nagarkatti
Role of Dioxin Response Element and Nuclear Factor-{kappa}B Motifs in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Regulation of Fas and Fas Ligand Expression
Mol. Pharmacol., January 1, 2007; 71(1): 145 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. J. Ross, S. Martinka, V. D. D'Agati, and L. A. Bruggeman
NF-{kappa}B Regulates Fas-Mediated Apoptosis in HIV-Associated Nephropathy
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2403 - 2411.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. A. Camacho, N. Singh, V. L. Hegde, M. Nagarkatti, and P. S. Nagarkatti
Treatment of Mice with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Leads to Aryl Hydrocarbon Receptor-Dependent Nuclear Translocation of NF-{kappa}B and Expression of Fas Ligand in Thymic Stromal Cells and Consequent Apoptosis in T Cells
J. Immunol., July 1, 2005; 175(1): 90 - 103.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-R. Li and L. J. Berg
Cutting Edge: Itk Is Not Essential for CD28 Signaling in Naive T Cells
J. Immunol., April 15, 2005; 174(8): 4475 - 4479.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Vacchio and R. J. Hodes
Fetal Expression of Fas Ligand Is Necessary and Sufficient for Induction of CD8 T Cell Tolerance to the Fetal Antigen H-Y during Pregnancy
J. Immunol., April 15, 2005; 174(8): 4657 - 4661.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Askenasy, E. S. Yolcu, I. Yaniv, and H. Shirwan
Induction of tolerance using Fas ligand: a double-edged immunomodulator
Blood, February 15, 2005; 105(4): 1396 - 1404.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Hess, P. Angel, and M. Schorpp-Kistner
AP-1 subunits: quarrel and harmony among siblings
J. Cell Sci., December 1, 2004; 117(25): 5965 - 5973.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement